PMN260

N/A

Report date: 2025/11/03 16:30:03

Base Information

Drug NamePMN260
Drug Alias NamePMN-260
ClassificationVaccines
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsTDP-43 Proteinopathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProMIS Neurosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesProMIS Neurosciences Inc
Inactive CompaniesN/A
Active IndicationsTDP-43 Proteinopathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A